Inventor · disambiguated record
Tina Devries
Also filed as: DEVRIES TINA · DEVRIES TINA M
17 granted patents·7 pending applications·375 citations·filing 2000–2023
94Inventor score
Files withRVL PHARMACEUTICALS INC10WARNER CHILCOTT CO INC3WARNER CHILCOTT CO LLC3WARNER CHILCOTT LAB IRELAND LT2DEVRIES TINA1
Top patents by PatentIndex Score
24 records- 0196US6521247B1Dual iron containing nutritional supplementWARNER CHILCOTT LAB IRELAND LT·Filed 2000·Granted Feb 18, 2003·94 cites·56 claims
- 0296US6495177B1Orally dissolvable nutritional supplementWARNER CHILCOTT LAB IRELAND LT·Filed 2000·Granted Dec 17, 2002·110 cites·29 claims
- 0391US7572779B2Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparationWARNER CHILCOTT CO LLC·Filed 2004·Granted Aug 11, 2009·58 cites·5 claims
- 0491US6962908B2Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparationWARNER CHILCOTT CO INC·Filed 2001·Granted Nov 8, 2005·62 cites·7 claims
- 0591US6667050B1Chewable oral contraceptiveGALEN CHEMICALS LTD·Filed 2001·Granted Dec 23, 2003·37 cites·60 claims
- 0687US10898573B1Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2020·Granted Jan 26, 2021·1 cites·30 claims
- 0785US10814001B1Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2019·Granted Oct 27, 2020·2 cites·19 claims
- 0885US2024033250A1Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0982US11701343B2Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2022·Granted Jul 18, 2023·0 cites·28 claims
- 1082US11541036B2Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2022·Granted Jan 3, 2023·0 cites·16 claims
- 1181US10799481B1Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2019·Granted Oct 13, 2020·1 cites·30 claims
- 1280US8415331B2Doxycycline metal complex in a solid dosage formDEVRIES TINA·Filed 2008·Granted Apr 9, 2013·3 cites·8 claims
- 1379US11311515B2Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·0 cites·29 claims
- 1477US11324722B2Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2021·Granted May 10, 2022·0 cites·23 claims
- 1577US7485319B2Doxycycline metal complex in a solid dosage formWARNER CHILCOTT CO INC·Filed 2004·Granted Feb 3, 2009·7 cites·11 claims
- 1676US11103482B2Oxymetazoline compositionsRVL PHARMACEUTICALS INC·Filed 2021·Granted Aug 31, 2021·0 cites·20 claims
- 1775US10940138B2Compositions and methods for treating ocular disordersRVL PHARMACEUTICALS INC·Filed 2020·Granted Mar 9, 2021·0 cites·30 claims
- 1855US7799771B2Oral pharmaceutical products containing 17β-estradiol-3-lower alkanoate, method of administering the same and process of preparationWARNER CHILCOTT CO LLC·Filed 2005·Granted Sep 21, 2010·0 cites·7 claims
- 1954US2007286819A1Methods to administer ethinyl estradiol and prodrugs thereof with improved bioavailabilityWARNER CHILCOTT CO INC·Filed 2007·Application pending·0 cites
- 2053US2005038005A1Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycleFiled 2004·Application pending·0 cites
- 2149US2006183719A1Tetracycline metal complex in a solid dosage formDEVRIES TINA M·Filed 2006·Application pending·0 cites
- 2248US2005176693A1Method of intermittent administration of a pharmaceutical for the treatment of conditions associated with a female's menstrual cycleFiled 2005·Application pending·0 cites
- 2340US2013302442A1Methods of using (4s,4as,5ar,12as)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amidePARATEK PHARM INNC·Filed 2013·Application pending·0 cites
- 2438US2015258117A1Low-dose estradiol creamWARNER CHILCOTT CO LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tina Devries files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →